IBOV 174,586.26 ▲ 0.01% IPSA 11,369.18 ▼ 0.71% IPC MEX 66,191.11 ▼ 0.15% MERVAL 3,024,971 — 0.00% COLCAP 2,504.68 ▼ 0.15% BVL PERÚ 60,449.35 ▲ 0.30% USD/BRL5.15▲ 0.08% USD/MXN16.96▲ 0.04% USD/CLP921.93▲ 0.03% USD/COP3,128▲ 1.09% USD/PEN3.35▲ 0.27% USD/ARS1,500▼ 0.94% USD/UYU40.18▲ 1.55% USD/PYG5,957▲ 0.99% USD/BOB11.50▲ 1.47% USD/DOP58.01▲ 0.33% USD/CRC450.21▲ 2.07% USD/GTQ7.62▲ 2.21% USD/HNL26.82▲ 0.34% USD/NIO36.62▲ 0.79% USD/VES789.35▲ 0.36% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.73▲ 1.10% EUR/BRL6.00▼ 0.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 174,586.26 ▲ 0.01% IPSA 11,369.18 ▼ 0.71% IPC MEX 66,191.11 ▼ 0.15% MERVAL 3,024,971 — 0.00% COLCAP 2,504.68 ▼ 0.15% BVL PERÚ 60,449.35 ▲ 0.30% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Thursday, August 27, 2026

Covid-19 Brazil

Brazil’s União Química completes first batch of Russian Covid-19 Sputnik V vaccine

By · May 21, 2021 · 2 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – União Química has completed the production of its first batch of the Sputnik V coronavirus vaccine with active ingredients and technology supplied by Russia, the Brazilian pharmaceutical company announced Thursday, May 20.

União Química will be capable of producing 8 million doses per month once the Brazilian Health Regulatory Agency (ANVISA) has approved its use in Brazil, said chief executive Fernando Marques (Photo internet reproduction)
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
Latin American markets, currencies and companies.
Open the full Ask Rio Times →

The vaccine will be exported to neighboring South American countries, as Brazil’s health regulator ANVISA has not authorized the Russian vaccine for domestic use.

Moscow’s Gamaleya Institute, which developed the vaccine, said it was in charge of the quality control of the vaccine’s ingredients, which was bottled at União Química’s unit in the city of Guarulhos, São Paulo.

The plant’s first batch of 100,000 doses was packaged in Spanish-labeled boxes, but the destination countries have not yet been chosen by the Russian Direct Investment Fund (RDIF), executives said.

Fernando Marques, chief executive of the Brazilian family-owned company, said that Paraguay, Uruguay and Argentina are interested in buying the vaccine. União Química will be capable of producing 8 million doses per month once ANVISA has approved its use in Brazil, he said.

ANVISA’s approval was deferred because the agency challenged some documents and said it was missing trial data that had been requested from the Russian fund, which is marketing the vaccine.

Marques expects approval in June, and his company will start producing the active ingredient in its biomedical lab in Brasilia, rather than importing it from Russia.

The Russian fund said it has signed Sputnik V production contracts with 20 manufacturing facilities in India, Argentina, South Korea, China, Italy, Serbia, Egypt, Turkey, Belarus, and Kazakhstan.

The vaccine is currently produced in Russia, Serbia, Egypt, Turkey and Argentina, where the first trial batch was produced on April 20 by Richmond Laboratories, the Russian fund said.

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.